Adyen NV
SWB:1N8
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Adyen NV
SWB:1N8
|
NL |
|
S
|
Stryker Corp
F:SYK
|
US |
|
Celldex Therapeutics Inc
NASDAQ:CLDX
|
US |
|
Old Mutual Ltd
LSE:OMU
|
ZA |
|
T
|
Tegna Inc
XBER:GTT
|
US |
|
P
|
Persimmon PLC
DUS:OHP
|
UK |
|
B
|
Barrick Gold Corp
DUS:ABR
|
CA |
|
C
|
Clicks Group Ltd
JSE:CLS
|
ZA |
|
Ferrovial SA
F:UFG
|
ES |
Wall St Price Targets
1N8 Price Targets Summary
Adyen NV
According to Wall Street analysts, the average 1-year price target for 1N8 is 1 451.98 EUR with a low forecast of 950.21 EUR and a high forecast of 1 979.85 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 1N8's stock price target?
Price Target
1 451.98
EUR
According to Wall Street analysts, the average 1-year price target for 1N8 is 1 451.98 EUR with a low forecast of 950.21 EUR and a high forecast of 1 979.85 EUR.
What is the Revenue forecast for Adyen NV?
Projected CAGR
15%
Over the last 10 years, the compound annual growth rate for Revenue has been 23%. The projected CAGR for the next 8 years is 15%.
What is the Operating Income forecast for Adyen NV?
Projected CAGR
21%
Over the last 10 years, the compound annual growth rate for Operating Income has been 39%. The projected CAGR for the next 8 years is 21%.
What is the Net Income forecast for Adyen NV?
Projected CAGR
17%
Over the last 10 years, the compound annual growth rate for Net Income has been 41%. The projected CAGR for the next 8 years is 17%.
